Omar Ahmed, Azza Elbadri, Aziz Momin and Riyaz A Kaba*
Volume3-Issue11
Dates: Received: 2022-10-27 | Accepted: 2022-11-25 | Published: 2022-11-28
Pages: 1404-1407
Abstract
The most common age range for Atrial Fibrillation (AF) prevalence over the coming decades will potentially be in those over 75 years old. However, despite widespread recognition of the strong association between AF burden and age, the elderly are under-represented within trials evaluating invasive rhythm control strategies. We report the outcomes of a gentleman in his late eighties that underwent Convergent hybrid ablation for highly symptomatic and longstanding persistent AF. Now four years later and into his nineties, he remains in sinus rhythm and enjoys good cardiac health without the need for anti-arrhythmic drugs or further intervention. To our knowledge, this case report is the oldest patient to have successfully undergone Convergent ablation with enduring sinus rhythm with long-term follow-up, despite significant risk factors for AF recurrence. As the overall population ages, the emergence of this minimally invasive multidisciplinary ablation technique for AF may offer to similar patients benefits over percutaneous ablation strategies alone.
FullText HTML
FullText PDF
DOI: 10.37871/jbres1611
Certificate of Publication
Copyright
© 2022 Ahmed O, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Ahmed O, Elbadri A, Momin A, Kaba RA. Successful 4-Year Outcome Following Convergent Ablation for Longstanding Persistent Atrial Fibrillation in an Octogenarian – Novel Therapy for an Old Condition in the Very Elderly. 2022 Nov 28; 3(11): 1404-1407. doi: 10.37871/jbres1611, Article ID: JBRES1611, Available at: https://www.jelsciences.com/articles/jbres1611.pdf
Subject area(s)
References
- Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: A report from the american heart association. Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659. Erratum in: Circulation. 2020 Jan 14;141(2):e33. PMID: 30700139.
- Lane DA, Skjøth F, Lip GYH, Larsen TB, Kotecha D. Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care. J Am Heart Assoc. 2017 Apr 28;6(5):e005155. doi: 10.1161/JAHA.116.005155. PMID: 28455344; PMCID: PMC5524079.
- Aldrugh S, Sardana M, Henninger N, Saczynski JS, McManus DD. Atrial fibrillation, cognition and dementia: A review. J Cardiovasc Electrophysiol. 2017 Aug;28(8):958-965. doi: 10.1111/jce.13261. Epub 2017 Jun 21. PMID: 28569383; PMCID: PMC5783292.
- Camm AJ, Naccarelli GV, Mittal S, Crijns HJGM, Hohnloser SH, Ma CS, Natale A, Turakhia MP, Kirchhof P. The increasing role of rhythm control in patients with atrial fibrillation: JACC State-of-the-art review. J Am Coll Cardiol. 2022 May 17;79(19):1932-1948. doi: 10.1016/j.jacc.2022.03.337. PMID: 35550691.
- Rashid M, Fischman DL, Gulati M, Tamman K, Potts J, Kwok CS, Ensor J, Shoaib A, Mansour H, Zaman A, Savage MP, Mamas Ma. Temporal trends and inequalities in coronary angiography utilisation in the management of non-ST-Elevation acute coronary syndromes in the US. Sci Rep. 2019;9(1):240. doi: 10.1038/s41598-018-36504-y
- DeLurgio DB, Ferguson E, Gill J, Blauth C, Oza S, Mostovych M, Awasthi Y, Ndikintum N, Crossen K. Convergence of epicardial and endocardial RF ablation for the treatment of symptomatic persistent AF (CONVERGE Trial): Rationale and design. Am Heart J. 2020 Jun;224:182-191. doi: 10.1016/j.ahj.2020.02.016. Epub 2020 Feb 29. PMID: 32416333.
- Fumagalli S, Said SAM, Laroche C, Gabbai D, Marchionni N, Boriani G, Maggioni AP, Popescu MI, Rasmussen LH, Crijns HJGM, Lip GYH; EORP-AF Investigators. Age-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in europe: The EORP-AF general pilot registry (EURObservational Research Programme-Atrial Fibrillation). JACC Clin Electrophysiol. 2015 Aug;1(4):326-334. doi: 10.1016/j.jacep.2015.02.019. Epub 2015 Apr 20. PMID: 29759321.
- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (EACTS): The task force for the diagnosis and management of atrial fibrillation of the european society of cardiology (ESC) developed with the special contribution of the european heart rhythm association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021 Feb 1;42(5):507. Erratum in: Eur Heart J. 2021 Feb 1;42(5):546-547. Erratum in: Eur Heart J. 2021 Oct 21;42(40):4194. PMID: 32860505.
- Brooks AG, Stiles MK, Laborderie J, Lau DH, Kuklik P, Shipp NJ, Hsu LF, Sanders P. Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review. Heart Rhythm. 2010 Jun;7(6):835-846. doi: 10.1016/j.hrthm.2010.01.017. Epub 2010 Jan 22. PMID: 20206320.
- McCready JW, Smedley T, Lambiase PD, Ahsan SY, Segal OR, Rowland E, Lowe MD, Chow AW. Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. Europace. 2011 Mar;13(3):355-361. doi: 10.1093/europace/euq434. Epub 2010 Dec 8. PMID: 21148171.
- Betts TR. Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: Still a valid treatment in appropriately selected patients. Europace. 2008 Apr;10(4):425-432. doi: 10.1093/europace/eun063. Epub 2008 Mar 12. PMID: 18339612.
- Elbadri A, Gukop P, Gallagher M. Results of minimally invasive hybrid ablation therapy for longstanding persistent AF. European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):160.
- On YK, Park KM, Jeong DS, Park PW, Lee YT, Park SJ, Kim JS. Electrophysiologic results after thoracoscopic ablation for chronic atrial fibrillation. Ann Thorac Surg. 2015 Nov;100(5):1595-1602; discussion 1602-1603. doi: 10.1016/j.athoracsur.2015.04.127. Epub 2015 Jul 26. PMID: 26215779.
- Fumagalli S, Nieuwlaat R, Tarantini F, de Vos CB, Werter CJ, Le Heuzey JY, Marchionni N, Crijns HJ. Characteristics, management and prognosis of elderly patients in the euro heart survey on atrial fibrillation. Aging Clin Exp Res. 2012 Oct;24(5):517-523. doi: 10.3275/8408. Epub 2012 May 8. PMID: 22572627.
